Cognition Therapeutics, Inc. (CGTX) Misses Q1 EPS by 3c

Cognition Therapeutics, Inc. (NASDAQ: CGTX) reported Q1 EPS of ($0.14), $0.03 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on Cognition Therapeutics, Inc. (CGTX) click here.

You May Also Be Interested In

• Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
• Bernstein SocGen on Howmet Aerospace Inc. (HWM): 'Stock is down on the SpaceX comments; should be a buying opportunity'
• Bernstein SocGen on Meta Platforms Inc. (META): 'When does Meta overtake Google Search?'